Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; LEQEMBI is a humanized immunoglobulin gamma 1 (IgG1); Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provid...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 81 3 3817 3700
Address:
4-6-10, Koishikawa, Bunkyo-ku, Tokyo, Japan
